Felipe Santiago
Fernández Vázquez
Profesor Asociado CC. Salud
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (6)
2022
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2020
-
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002
2018
-
Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study
Catheterization and Cardiovascular Interventions, Vol. 91, Núm. 3, pp. 435-443
2016
-
Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)
American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584
2013
-
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958
2011
-
Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart
Journal of the American College of Cardiology, Vol. 58, Núm. 9, pp. 977-986